Vitamin D Supplementation on Outcome and Disease Activity.

• Status: Recruiting
• Trial end date: 2022-05-01
• Target enrollment: 0
• Participant gender: All

Summary

To study efficacy of Vitamin D on outcome and disease activity ; DAS28-ESR in Rheumatoid arthritis patients at Rajavithi hospital .

• Phase: N/A
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Rajavithi Hospital
• Treatments: Ergocalciferols; Vitamin D

Criteria

Inclusion Criteria:

• Age > 18 yrs old

• RA diagnosed by ACR/EULAR 2010

• low to moderate disease activity

• on stable NSAIDs and DMARDs for at least 1 month

• Received Prednisolone less than or equal to 7.5 mg/day

• serum calcium, phosphorus and ALP are within normal limit.

Exclusion Criteria:

• Chronic kidney disease stage 3 or higher

• History of TB

• History of Chronic liver disease

• Pregnancy or breast-feeding

• adjustment of immuno-suppressive drugs, steroid

• other connective tissue disease

• Vitamin D allergy

• received other drugs which have vitamin D component

• serum Vitamin D less than 10 ng/mL